Metronidazole NDC 72578-209

NDC codes

FDA NDC Directory

Product NDC (as listed)72578-209Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72578-0209Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72578-209-04	72578020904	1 TUBE in 1 CARTON (72578-209-04) / 45 g in 1 TUBEMarketed from Feb 14, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metronidazole
Generic name (nonproprietary): metronidazole
Active ingredients: Metronidazole — 7.5 mg/g
Dosage form: Gel
Route: Topical
Labeler: Viona Pharmaceuticals Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220095
Marketing start: Feb 14, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Nitroimidazoles (Chemical structure)
Identifiers: Product ID 72578-209_90a3bb34-53e8-4f44-b583-e30f0e2b8727SPL ID 90a3bb34-53e8-4f44-b583-e30f0e2b8727SPL set ID 40a8c59b-a46d-4e5b-bd38-330cdbc1022cRxCUI 311679UNII 140QMO216E
Pharmacologic class: Nitroimidazole Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472578020904 followed by a unit qualifier and the quantity

Package 72578-0209-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 19, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Metronidazole Gel is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 220095

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220095
Product	Strength	Form · route	Labeler	Product NDC
Metronidazole	Metronidazole 7.5 mg/g	GelTopical	Zydus Lifesciences Limited	70771-1978